DDTC-Cu(I) inhibits human osteosarcoma cells growth by repressing MET/PI3K/AKT signaling pathway
Abstract Osteosarcoma (OS) is a frequently occurring bone malignancy with increased metastatic properties, causing deaths in large numbers around the world. Disulfiram (DSF) is clinically utilized to treat alcohol dependency and has been indicated to bind Cu(I) in-vivo to form DDTC-Cu(I), which has...
Saved in:
| Main Authors: | Ruhao Zhou, Lei Yan, Kun Zhang, Song Chen, Yang Yu, Xiaochun Wei, Yongchun Pan, Chaojian Xu, Xiaojuan Sun, Zhi Lv, Pengcui Li, Xiaochen Qiao, Yi Feng, Zhi Tian |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-06748-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Urolithin A suppressed osteosarcoma cell migration and invasion via targeting MMPs and AKT1
by: Abdolreza Ahmadi, et al.
Published: (2025-07-01) -
The metastatic role of the CXCL10-CXCR3 axis and its therapeutic potential in osteosarcoma
by: Benjamin B. Gyau, et al.
Published: (2025-06-01) -
Response to crizotinib in advanced intrahepatic cholangiocarcinoma with ZKSCAN1-MET fusion and MET amplification: case reports and literature review
by: Jian-Hui Wu, et al.
Published: (2025-06-01) -
LONG NON-CODING RNAs AND AUTOPHAGY IN OSTEOSARCOMA
by: Ayça Coşkun, et al.
Published: (2022-08-01) -
MET mutation causes muscular dysplasia and arthrogryposis
by: Hang Zhou, et al.
Published: (2019-02-01)